Pricing Log in Create free account
Friday 6 November 2026 Export SYK’s income statement to Excel — free account

Stryker Corporation

SYK Healthcare Medical Devices

Stryker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $25.1 billion, up 11.2% from fiscal 2024.

Revenue
+7.64%
EPS
−12.4%
Free cash flow
−19.4%
Total debt
−10.0%

Quarter to September 2026, against a year earlier

324.26 10.82 −3.23%
Market cap
$127.6B
P/E
34.3×
Fwd P/E
24.6×
Dividend yield
1.09%
F-score
5/9
Altman Z
4.81
Beneish M
−2.62
Dividend safety
82/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Stryker Corporation (SYK) EV/EBITDA

Alert me on EV/EBITDA

As of 6 November 2026, Stryker Corporation (SYK) trades at a EV/EBITDA of 20.4×. Over the past ten years it has ranged from 14.6× (January 2016) to 37.9× (April 2021); the current reading is higher than 25% of that period. That is above the Medical Devices industry median of 11.4× and above the Healthcare sector median of 8.5×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 24.0× (22.18%)
FY2024 30.9× 23.99%
FY2023 24.9× (8.25%)
FY2022 27.1× (12.06%)
FY2021 30.9× (9.06%)
FY2020 33.9× 39.06%
FY2019 24.4× 22.76%
FY2018 19.9× (7.98%)
FY2017 21.6× 21.92%
FY2016 17.7× 14.56%

Quarterly newest first

Period EV/EBITDA Change
Sep 2026 17.6× (10.04%)
Jun 2026 19.6× (11.67%)
Mar 2026 22.2× (7.76%)
Dec 2025 24.0× (25.32%)
43 more quarters

Against its own ten years

Low 14.6× High 37.9×
Ten-year median 24.9×
Current reading's percentile 25

EV/EBITDA against peers

Company EV/EBITDA
PHG Koninklijke Philips N.V. compare 11.1×
GEHC GE HealthCare Technologies Inc. compare 13.1×
BSX Boston Scientific Corporation compare 13.6×
MDT Medtronic PLC compare 15.4×
STE STERIS plc compare 15.6×
DXCM DexCom, Inc. compare 20.0×
SYK Stryker Corporation 20.4×
ABT Abbott Laboratories compare 20.6×
EW Edwards Lifesciences Corporation compare 34.3×
Medical Devices industry median 11.4×
Healthcare sector median 8.5×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on SYK